Pacific Biosciences of California, Inc.
PACB· Nasdaq
PACBPacific Biosciences of California, Inc.
Released Oct 30, 2023, after the close
10-Q filed Nov 3, 2023, 34 days after period end · 0001299130-23-000139
| Metric | Q3 2023 | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|---|
| Revenue | $55.69M | $32.31M | $34.89M | $19.08M |
| Net Income | -$66.87M | -$76.97M | $16.54M | -$23.71M |
| EPS Diluted |
Pacific Biosciences of California, Inc. · CIK 1299130 · Engraved from SEC EDGAR
| -$0.26 |
| -$0.34 |
| $0.08 |
| -$0.14 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
